Many drugs come in two forms: expensive branded drugs and cheaper generic copies. Switzerland’s Federal Council hopes a shift to cheaper generic and bio-similar medicines can shave CHF 250 million fro …
Read Full Story at source (may require registration)
- What is Meant by “Discovery” in Sales? A Strategy for Building Trust and Driving Conversions - March 12, 2025
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024